Clinical trials
Dry Eye Syndromes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
103 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 12 |
| 2021 | 14 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 10 |
| 2025 | 6 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Unknown status | 33 |
| Recruiting | 13 |
| Not yet recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Third Hospital | 13 |
| He Eye Hospital | 11 |
| Beijing Tongren Hospital | 8 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 7 |
| Sun Yat-sen University | 3 |
| Tianjin Eye Hospital | 3 |
| Zhongnan Hospital | 3 |
| Corxel Pharmaceuticals | 2 |
| Eye & ENT Hospital of Fudan University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 103 |
| Meibomian Gland Dysfunction | 10 |
| Asthenopia | 7 |
| Sjogren's Syndrome | 5 |
| Cataract | 4 |
| Blepharospasm | 2 |
| Diabetes Mellitus | 2 |
| Eye Diseases | 2 |
| Inflammation | 2 |
| Amblyopia | 1 |
Trials
Showing 76 to 100 of 103. Each trial links to its page on Pharma Observatory.
3 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.